 |
| Image: ennislaw.com |
On the 13th January 2004 promising medical student, 22 year old Jon Medland, hanged himself at his student lodgings at Manchester University.
Jon had suffered from mild acne on his back and had, four weeks previous, been prescribed Roaccutane, a drug used to treat severe cases of acne.
At his inquest Manchester coroner, said: "For a drug to affect a person of a very solid life foundation, if it can lead them to take their own life, then it deserves further investigation, if a link can be proved.
"But I cannot say with any certainty that the effects of the drug Roaccutane led him to take his own life. All I can say is that the warnings that are already present should be made very clearly and strongly."
Roaccutane is from the stable of Hoffman-La Roche and has many different brand names. Accutane in the United States before July 2009), Amnesteem (Mylan), Claravis (Barr), Clarus (PremPharm), Decutan (Actavis), Isotane (Pacific Pharmaceuticals), Izotek (BlauFarma), Oratane (Genepharm Australasia), ISOTRET (Liva Healthcare Ltd.) or Sotret (Ranbaxy), while topical isotretinoin is most commonly marketed under the trade names Isotrex or Isotrexin (Stiefel)
It is also a known teratogen, so should not be administered to women who are pregnant...no doubt it still is due to the carte blanch doctors have of prescribing these type of drugs because the MHRA have very little, or no power, to ban them.
In the following three minute video, Jon's father, Jonathon Medland Snr, is interviewed by founder of the APRIL charity, Millie Kleve. APRIL stands for Adverse Psychiatric Reactions Information Link and is a charity that creates awareness and collates information about adverse psychiatric side effects of everyday medicines and anaesthetics.
Jonathon describes the moment he met Prof. Kent Woods, CEO of the MHRA in London.
A father talks about the acne drug Roaccutane his son's suicide and the attitude of regulators from APRIL on Vimeo.
More on Jon Medland's suicide HERE
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
No comments: